Moringa leaves prevent hepatic lipid accumulation and inflammation in guinea pigs by reducing the expression of genes involved in lipid metabolism

International Journal of Molecular Sciences

Volumn 18, Issue 7, 2017, Pages

  Almatrafi, Manal Mused ^a   Vergara Jimenez, Marcela ^b   Murillo, Ana Gabriela ^a   Norris, Gregory H ^a   Blesso, Christopher N ^a   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

Author keywords

Gene expression; Guinea pigs; Hepatic steatosis; Inflammation; Lipid accumulation; Moringa oleifera

Indexed keywords

CD8 ANTIGEN; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; CYTOKINE; DIACYLGLYCEROL ACYLTRANSFERASE 2; GAMMA INTERFERON; INTERLEUKIN 1BETA; MORINGA OLEIFERA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; LIPID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG MEGADOSE; FATTY LIVER; FLUOROMETRY; GENE EXPRESSION; GUINEA PIG; HISTOLOGY; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LOW DRUG DOSE; MALE; MORINGA OLEIFERA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT LEAF; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS; ANIMAL; ANIMAL FOOD; BLOOD; CHEMISTRY; DIET; EATING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; LIVER; METABOLISM; MORINGA; PATHOLOGY;

ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; DIET; EATING; FATTY LIVER; GENE EXPRESSION REGULATION; GUINEA PIGS; INFLAMMATION; LIPID METABOLISM; LIPIDS; LIVER; MALE; MORINGA;

EID: 85021392010     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18071330     Document Type: Article

References (54)

1. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2014, 346, 1221–1231.[CrossRef] [PubMed]
2. Tolman, K.G.; Dalpiaz, A.S. Treatment of non-alcoholic fatty liver disease. Ther. Clin. Risk Manag. 2007, 3, 1153–1163. [PubMed]
3. Krawczyk, M.; Bonfrate, L.; Portincasa, P. Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 2010, 24, 695–708.[CrossRef] [PubMed]
4. Abenavoli, L.; Milic, N.; Peta, V.; Alfieri, F.; de Lorenzo, A.; Bellentani, S. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J. Gastroenterol. 2014, 20, 16831–16840.[CrossRef] [PubMed]
5. Masarone, M.; Federico, A.; Abenavoli, L.; Loguercio, C.; Persico, M. Non alcoholic fatty liver: Epidemiology and natural history. Rev. Recent Clin. Trials 2014, 9, 126–133.[CrossRef] [PubMed]
6. Murillo, A.; DiMarco, D.; Fernandez, M. The potential of non-provitamin A carotenoids for the prevention and treatment of non-alcoholic fatty liver disease. Biology 2016, 5,42.[CrossRef] [PubMed]
7. Li, S.; Tan, H.-Y.; Wang, N.; Zhang, Z.-J.; Lao, L.; Wong, C.-W.; Feng, Y. The role of oxidative stress and antioxidants in liver diseases. Int. J. Mol. Sci. 2015, 16, 26087–26124.[CrossRef] [PubMed]
8. Leone, A.; Spada, A.; Battezzati, A.; Schiraldi, A.; Aristil, J.; Bertoli, S. Moringa oleifera seeds and oil: Characteristics and uses for human health. Int. J. Mol. Sci. 2016, 17,2141.[CrossRef] [PubMed]
9. Leone, A.; Spada, A.; Battezzati, A.; Schiraldi, A.; Aristil, J.; Bertoli, S. Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology ofMoringa oleifera leaves: An overview. Int. J.Mol. Sci. 2015, 16, 12791–12835.[CrossRef] [PubMed]
10. Adedapo, A.A.; Falayi, O.O.; Oyagbemi, A.A. Evaluation of the analgesic, anti-inflammatory, anti-oxidant, phytochemical and toxicological properties of the methanolic leaf extract of commercially processed Moringa oleifera in some laboratory animals. J. Basic Clin. Physiol. Pharmacol. 2015, 26, 491–499.[CrossRef] [PubMed]
11. Al-Asmari, A.K.; Al-Elaiwi, A.M.; Athar, M.T.; Tariq, M.; Al Eid, A.; Al-Asmary, S.M. A review of hepatoprotective plants used in Saudi traditional medicine. Evid. Based Complement. Altern. Med. 2014, 2014,890842.[CrossRef] [PubMed]
12. Ghasi, S.; Nwobodo, E.; Ofili, J.O. Hypocholesterolemic effects of crude extract of leaf of Moringa oleifera Lam in high-fat diet fed wistar rats. J. Ethnopharmacol. 2000, 69, 21–25.[CrossRef]
13. Fakurazi, S.; Hairuszah, I.; Nanthini, U. Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem. Toxicol. 2008, 46, 2611–2615.[CrossRef] [PubMed]
14. Jaiswal, D.; Rai, P.K.; Kumar, A.; Mehta, S.; Watal, G. Effect of Moringa oleifera Lam leaves aqueous extract therapy on hyperglycemic rats. J. Ethnopharmacol. 2009, 123, 392–396.[CrossRef] [PubMed]
15. Jaiswal, D.; Rai, P.K.; Mehta, S.; Chatterji, S.; Shukla, S.; Rai, D.K.; Sharma, G.; Sharma, B.; Khair, S.; Watal, G. Role of Moringa oleifera in regulation of diabetes-induced oxidative stress. Asian Pac. J. Trop. Med. 2013, 6, 426–432.[CrossRef]
16. Nandave, M.; Ojha, S.K.; Joshi, S.; Kumari, S.; Arya, D.S. Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: Evidence for an antioxidant, antiperoxidative, and cardioprotective intervention. J. Med. Food 2009, 12, 47–55.[CrossRef] [PubMed]
17. Mehta, L.K.; Balaraman, R.; Amin, A.H.; Bafna, P.A.; Gulati, O.D. Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits. J. Ethnopharmacol. 2003, 86, 191–195.[CrossRef]
18. Chávez-Santoscoy, R.A.; Gutiérrez-Uribe, J.A.; Serna-Saldívar, S.O. Effect of flavonoids and saponins extracted from black bean (Phaseolus vulgaris L.) seed coats as cholesterol micelle disruptors. Plant Foods Hum. Nutr. 2013, 68, 416–423.[CrossRef] [PubMed]
19. Minaiyan, M.; Asghari, G.; Taheri, D.; Saeidi, M.; Nasr-Esfahani, S. Anti-inflammatory effect of Moringa oleifera Lam seeds on acetic acid-induced acute colitiis in rats. Avicenna J. Phytomed. 2014, 4, 127–136. [PubMed]
20. Singh, B.N.; Singh, B.R.; Singh, R.L.; Prakash, D.; Dhakarey, R.; Upadhyay, G.; Singh, H.B. Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food Chem. Toxicol. 2009, 47, 1109–1116.[CrossRef] [PubMed]
21. Labbe, D.; Provencal, M.; Lamy, S.; Boivin, D.; Gingras, D.; Beliveau, R.; Be, R.; Provenc, M. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J. Nutr. 2009, 139, 646–652.[CrossRef] [PubMed]
22. Pari, L.; Kumar, N.A. Hepatoprotective activity of Moringa oleifera on antitubercular drug-induced liver damage in rats. J. Med. Food 2002, 5, 171–177.[CrossRef] [PubMed]
23. Sharifudin, S.A.; Fakurazi, S.; Hidayat, M.T.; Hairuszah, I.; Aris Mohd Moklas, M.; Arulselvan, P. Therapeutic potential of Moringa oleifera extracts against acetaminophen-induced hepatotoxicity in rats. Pharm. Biol. 2013, 51, 279–288.[CrossRef] [PubMed]
24. Hamza, A.A. Ameliorative effects of Moringa oleifera Lam seed extract on liver fibrosis in rats. Food Chem. Toxicol. 2010, 48, 345–355.[CrossRef] [PubMed]
25. Sinha, M.; Das, D.K.; Bhattacharjee, S.; Majumdar, S.; Dey, S. Leaf extract of Moringa oleifera prevents ionizing radiation-induced oxidative stress in mice. J. Med. Food 2011, 14, 1167–1172.[CrossRef] [PubMed]
26. Stohs, S.J.; Hartman, M.J. Review of the safety and efficacy of Moringa oleifera. Phytother. Res. 2015, 29, 796–804.[CrossRef] [PubMed]
27. Al-Sarraj, T.; Saadi, H.; Volek, J.S.; Fernandez, M.L. Carbohydrate restriction favorably alters lipoprotein metabolism in Emirati subjects classified with the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 720–726.[CrossRef] [PubMed]
28. Carr, T.P.; Andresen, C.J.; Rudel, L.L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 1993, 26, 39–42.[CrossRef]
29. Kim, J.E.; Leite, J.O.; Smyth, J.A.; Clark, R.M.; Fernandez, M.L. A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. J. Nutr. 2011, 141, 1458–1463.[CrossRef] [PubMed]
30. Murillo, A.G.; Aguilar, D.; Norris, G.H.; Dimarco, D.M.; Missimer, A.; Hu, S.; Smyth, J.A.; Gannon, S.; Blesso, C.N.; Luo, Y. et al. Compared with powdered lutein, a lutein nanoemulsion increases plasma and liver lutein, protects against hepatic steatosis, and affects lipoprotein metabolism in guinea pigs. J. Nutr. 2016, 146, 1961–1969.[CrossRef] [PubMed]
31. Farrell, N.; Norris, G.; Lee, S.G.; Chun, O.K.; Blesso, C.N. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice. Food Funct. 2015, 6, 1278–1287.[CrossRef] [PubMed]
32. Li, X.J.; Mu, Y.M.; Li, T.T.; Yang, Y.L.; Zhang, M.T.; Li, Y.S.; Zhang, W.K.; Tang, H.B.; Shang, H.C. Gynura procumbens reverses acute and chronic ethanol-induced liver steatosis through MAPK/SREBP-1c-dependent and -independent pathways. J. Agric. Food Chem. 2015, 63, 8460–8471.[CrossRef] [PubMed]
33. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review. Evid. Based Complement. Altern. Med. 2013, 2013, 801457.[CrossRef] [PubMed]
34. Gebregiorgis, F.; Negesse, T.; Nurfeta, A. Feed intake and utilization in sheep fed graded levels of dried Moringa (Moringa stenopetala) leaf as a supplement to Rhodes grass hay. Trop. Anim. Health Prod. 2012, 44, 511–517.[CrossRef] [PubMed]
35. Giannini, E.G.; Testa, R.; Savarino, V. Liver enzyme alteration: A guide for clinicians. Can. Med. Assoc. J. 2005, 172, 367–379.[CrossRef] [PubMed]
36. Ouédraogo, M.; Lamien-Sanou, A.; Ramdé, N.; Ouédraogo, A.S.; Ouédraogo, M.; Zongo, S.P.; Goumbri, O.; Duez, P.; Guissou, P.I. Protective effect of Moringa oleifera leaves against gentamicin-induced nephrotoxicity in rabbits. Exp. Toxicol. Pathol. 2013, 65, 335–339.[CrossRef] [PubMed]
37. Fernandez, M.L.; Vergara-Jimenez, M.; Conde, K.; Behr, T.; Abdel-Fattah, G. Regulation of apolipoprotein B-containing lipoproteins by dietary soluble fiber in guinea pigs. Am. J. Clin. Nutr. 1997, 65, 814–822. [PubMed]
38. Osono, Y.; Woollett, L.A.; Herz, J.; Dietschy, J.M. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J. Clin. Invest. 1995, 95, 1124–1132.[CrossRef] [PubMed]
39. Fernandez, M.L.; Ruiz, L.R.; Conde, A.K.; Sun, D.M.; Erickson, S.K.; McNamara, D.J. Psyllium reduces plasma LDL in guinea pigs by altering hepatic cholesterol homeostasis. J. Lipid Res. 1995, 36, 1128–1138. [PubMed]
40. Fernandez, M.L.; Vergara-Jimenez, M.; Conde, K.; Abdel-Fattah, G. Dietary carbohydrate type and fat amount alter VLDL and LDL metabolism in guinea pigs. J. Nutr. 1996, 126, 2494–2504. [PubMed]
41. Duprez, D.A.; Otvos, J.; Tracy, R.P.; Feingold, K.R.; Gross, M.D.; Lima, J.A.C.; Mackey, R.H.; Neaton, J.D.; Sanchez, O.A.; Jacobs, D.R. High-density lipoprotein subclasses and noncancer chronic inflammatory-related events versus cardiovascular events: The multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. 2015, 4, 1–14.[CrossRef] [PubMed]
42. Mutungi, G.; Waters, D.; Ratliff, J.; Puglisi, M.; Clark, R.M.; Volek, J.S.; Luz, M. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J. Nutr. Biochem. 2009, 21, 261–267.[CrossRef] [PubMed]
43. Ossoli, A.; Pavanello, C.; Calabresi, L. High-density lipoprotein, lecithin: Cholesterol acyltransferase, and atherosclerosis. Endocrinol. Metab. 2016, 31, 223–229.[CrossRef] [PubMed]
44. Barter, P.J.; Rye, K.-A. Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J. Lipid Res. 2012, 53, 1755–1766.[CrossRef] [PubMed]
45. De Ogburn, R.; Leite, J.O.; Ratliff, J.; Volek, J.S.; McGrane, M.M.; Fernandez, M.L. Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in guinea pigs. Comp. Med. 2012, 62, 109–115.
46. Atawodi, S.E.; Atawodi, J.C.; Idakwo, G.A.; Pfundstein, B.; Haubner, R.; Wuntele, G.; Bartsch, H.; Owen, R.W. Evaluation of the polypehnol content and antioxidant properties of methanol extracts of the leaves, stem and root barks of Moringa oleifera Lam. J. Med. Food 2010, 13, 710–716.[CrossRef] [PubMed]
47. Shi, H.; Dong, L.; Dang, X.; Liu, Y.; Jiang, J.; Wang, Y.; Lu, X.; Guo, X. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm. Res. 2013, 62, 581–587.[CrossRef] [PubMed]
48. Cho, A.S.; Jeon, S.M.; Kim, M.J.; Yeo, J.; Seo, K.I.; Choi, M.S.; Lee, M.K. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937–943.[CrossRef] [PubMed]
49. Horton, J.D. Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 2002, 30, 1091–1095.[CrossRef] [PubMed]
50. Ioannou, G.N. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol. Metab. 2016, 27, 84–95.[CrossRef] [PubMed]
51. Waterman, C.; Cheng, D.M.; Rojas-Silva, P.; Poulev, A.; Dreifus, J.; Lila, M.A.; Raskin, I. Stable, water extractable isothiocyanates from Moringa oleifera leaves attenuate inflammation in vitro. Phytochemistry 2014, 103, 114–122.[CrossRef] [PubMed]
52. Zheng, Z.; Shi, L.; Sheng, Y.; Zhang, J.; Lu, B.; Ji, L. Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals. Environ. Toxicol. Pharmacol. 2016, 46, 80–89.[CrossRef] [PubMed]
53. Suzuki, R.; Tobe, K.; Aoyama, M.; Sakamoto, K.; Ohsugi, M.; Kamei, N.; Nemoto, S.; Inoue, A.; Ito, Y.; Uchida, S. et al. Expression of DGAT2 in white adipose tissue is regulated by central leptin action. J. Biol. Chem. 2005, 280, 3331–3337.[CrossRef] [PubMed]
54. Casaschi, A.; Wang, Q.; Dang, K.O.; Richards, A.; Theriault, A. Intestinal Apolipoprotein B secretion is inhibited by the flavonoid quercitin: Potential role of microsomal triglyceride transfer protein and dicaylglycerol acyltranferase. Lipids 2002, 37, 547–652.[CrossRef]